| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689188 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2017 | 21 Pages |
Abstract
At list price, the introduction of carbetocin appears to provide improved clinical outcomes along with cost savings, though this is subject to uncertainty regarding the underlying data in efficacy, resource use, and cost.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Helen A. van der Nelson, Tim Draycott, Dimitrios Siassakos, Christopher W.H. Yau, Anthony J. Hatswell,